Literature DB >> 29127582

Lessons learned from participating in D3R 2016 Grand Challenge 2: compounds targeting the farnesoid X receptor.

Rui Duan1,2,3,4, Xianjin Xu1,2,3,4, Xiaoqin Zou5,6,7,8.   

Abstract

D3R 2016 Grand Challenge 2 focused on predictions of binding modes and affinities for 102 compounds against the farnesoid X receptor (FXR). In this challenge, two distinct methods, a docking-based method and a template-based method, were employed by our team for the binding mode prediction. For the new template-based method, 3D ligand similarities were calculated for each query compound against the ligands in the co-crystal structures of FXR available in Protein Data Bank. The binding mode was predicted based on the co-crystal protein structure containing the ligand with the best ligand similarity score against the query compound. For the FXR dataset, the template-based method achieved a better performance than the docking-based method on the binding mode prediction. For the binding affinity prediction, an in-house knowledge-based scoring function ITScore2 and MM/PBSA approach were employed. Good performance was achieved for MM/PBSA, whereas the performance of ITScore2 was sensitive to ligand composition, e.g. the percentage of carbon atoms in the compounds. The sensitivity to ligand composition could be a clue for the further improvement of our knowledge-based scoring function.

Entities:  

Keywords:  Binding affinity prediction; Binding mode prediction; D3R; Drug Design Data Resource; Drug discovery; Ligand similarity; Molecular docking; Scoring function; Template-based

Mesh:

Substances:

Year:  2017        PMID: 29127582      PMCID: PMC5767536          DOI: 10.1007/s10822-017-0082-x

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  25 in total

1.  Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation.

Authors:  Araz Jakalian; David B Jack; Christopher I Bayly
Journal:  J Comput Chem       Date:  2002-12       Impact factor: 3.376

2.  Accelerated Poisson-Boltzmann calculations for static and dynamic systems.

Authors:  Ray Luo; Laurent David; Michael K Gilson
Journal:  J Comput Chem       Date:  2002-10       Impact factor: 3.376

3.  A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations.

Authors:  Yong Duan; Chun Wu; Shibasish Chowdhury; Mathew C Lee; Guoming Xiong; Wei Zhang; Rong Yang; Piotr Cieplak; Ray Luo; Taisung Lee; James Caldwell; Junmei Wang; Peter Kollman
Journal:  J Comput Chem       Date:  2003-12       Impact factor: 3.376

4.  Development and testing of a general amber force field.

Authors:  Junmei Wang; Romain M Wolf; James W Caldwell; Peter A Kollman; David A Case
Journal:  J Comput Chem       Date:  2004-07-15       Impact factor: 3.376

5.  The PDBbind database: methodologies and updates.

Authors:  Renxiao Wang; Xueliang Fang; Yipin Lu; Chao-Yie Yang; Shaomeng Wang
Journal:  J Med Chem       Date:  2005-06-16       Impact factor: 7.446

6.  Comparative assessment of scoring functions on a diverse test set.

Authors:  Tiejun Cheng; Xun Li; Yan Li; Zhihai Liu; Renxiao Wang
Journal:  J Chem Inf Model       Date:  2009-04       Impact factor: 4.956

7.  Conformer generation with OMEGA: learning from the data set and the analysis of failures.

Authors:  Paul C D Hawkins; Anthony Nicholls
Journal:  J Chem Inf Model       Date:  2012-11-12       Impact factor: 4.956

8.  Improving binding mode and binding affinity predictions of docking by ligand-based search of protein conformations: evaluation in D3R grand challenge 2015.

Authors:  Xianjin Xu; Chengfei Yan; Xiaoqin Zou
Journal:  J Comput Aided Mol Des       Date:  2017-07-01       Impact factor: 3.686

9.  D3R grand challenge 2015: Evaluation of protein-ligand pose and affinity predictions.

Authors:  Symon Gathiaka; Shuai Liu; Michael Chiu; Huanwang Yang; Jeanne A Stuckey; You Na Kang; Jim Delproposto; Ginger Kubish; James B Dunbar; Heather A Carlson; Stephen K Burley; W Patrick Walters; Rommie E Amaro; Victoria A Feher; Michael K Gilson
Journal:  J Comput Aided Mol Des       Date:  2016-09-30       Impact factor: 3.686

10.  Identification of a nuclear receptor that is activated by farnesol metabolites.

Authors:  B M Forman; E Goode; J Chen; A E Oro; D J Bradley; T Perlmann; D J Noonan; L T Burka; T McMorris; W W Lamph; R M Evans; C Weinberger
Journal:  Cell       Date:  1995-06-02       Impact factor: 41.582

View more
  5 in total

1.  Sampling and refinement protocols for template-based macrocycle docking: 2018 D3R Grand Challenge 4.

Authors:  Sergei Kotelnikov; Andrey Alekseenko; Cong Liu; Mikhail Ignatov; Dzmitry Padhorny; Emiliano Brini; Mark Lukin; Evangelos Coutsias; Ken A Dill; Dima Kozakov
Journal:  J Comput Aided Mol Des       Date:  2019-12-26       Impact factor: 3.686

Review 2.  Improving small molecule virtual screening strategies for the next generation of therapeutics.

Authors:  Bentley M Wingert; Carlos J Camacho
Journal:  Curr Opin Chem Biol       Date:  2018-06-17       Impact factor: 8.822

3.  Public Data Set of Protein-Ligand Dissociation Kinetic Constants for Quantitative Structure-Kinetics Relationship Studies.

Authors:  Huisi Liu; Minyi Su; Hai-Xia Lin; Renxiao Wang; Yan Li
Journal:  ACS Omega       Date:  2022-05-26

4.  Predicting protein-ligand binding modes for CELPP and GC3: workflows and insight.

Authors:  Xianjin Xu; Zhiwei Ma; Rui Duan; Xiaoqin Zou
Journal:  J Comput Aided Mol Des       Date:  2019-01-28       Impact factor: 3.686

5.  D3R grand challenge 4: blind prediction of protein-ligand poses, affinity rankings, and relative binding free energies.

Authors:  Conor D Parks; Zied Gaieb; Michael Chiu; Huanwang Yang; Chenghua Shao; W Patrick Walters; Johanna M Jansen; Georgia McGaughey; Richard A Lewis; Scott D Bembenek; Michael K Ameriks; Tara Mirzadegan; Stephen K Burley; Rommie E Amaro; Michael K Gilson
Journal:  J Comput Aided Mol Des       Date:  2020-01-23       Impact factor: 3.686

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.